Chlorpheniramine / Methscopolamine / Phenylephrine Dosage
Medically reviewed by Drugs.com. Last updated on Oct 5, 2023.
Applies to the following strengths: 2 mg-0.625 mg-10 mg/5 mL; 8 mg-2.5 mg-20 mg; 2 mg-1.25 mg-10 mg/5 mL; 2 mg-1.25 mg-10 mg; 4 mg-1.25 mg-10 mg; 12 mg-2.5 mg-20 mg; ages 12 years and older; 2 mg-0.75 mg-8 mg/5 mL; 2 mg-0.75 mg-10 mg/5 mL; 4 mg-1.25 mg-10 mg/ 5 mL; 8 mg-1.25 mg-20 mg; 2 mg-1.5 mg-10 mg/5 mL; 8 mg-2.5 mg-25 mg; 2 mg-1.25 mg-15 mg; 2 mg-1.5 mg-10 mg; ages 6 years and older; 8 mg-2.5 mg-40 mg; 12 mg-2 mg-40 mg
Usual Adult Dose for:
Usual Pediatric Dose for:
Additional dosage information:
Usual Adult Dose for Nasal Congestion
Tablets:
chlorpheniramine/methscopolamine/PE 8 mg-1.25 mg-20 mg, extended release or
chlorpheniramine/methscopolamine/PE 8 mg-2.5 mg-25 mg, extended release or
chlorpheniramine/methscopolamine/PE 8 mg-2.5 mg-40 mg, extended release or
chlorpheniramine/methscopolamine/PE 12 mg-2.5 mg-20 mg extended release or
chlorpheniramine/methscopolamine/PE 12 mg-2 mg-40 mg, extended release or
chlorpheniramine/methscopolamine/PE 8 mg-2.5 mg-20 mg oral tablet, extended release:
1 tablet orally twice a day, not to exceed 2 doses per day.
chlorpheniramine/methscopolamine/PE 4 mg-1.25 mg-10 mg oral tablet or chlorpheniramine/methscopolamine/PE 2 mg-1.25 mg-10 mg oral tablet, chewable: 1 to 2 tablets orally every 12 hours, not to exceed 4 tablets per day.
chlorpheniramine/methscopolamine/PE varying strength oral tablet, extended release:
chlorpheniramine/methscopolamine/PE 2.5 mg-40 mg extended release: 1 tablet orally in the morning and
chlorpheniramine/methscopolamine/PE 8 mg-2.5 mg-10 mg extended release: 1 tablet orally in the evening.
chlorpheniramine/methscopolamine/PE ages 6 years and older oral tablet, extended release
chlorpheniramine/methscopolamine/PE 2 mg-1.5 mg-10 mg extended release: 1 or 2 tablets orally in the morning and
chlorpheniramine/methscopolamine/PE 2 mg--1.5 mg extended release: 1 or 2 tablets orally in the evening.
Liquid:
chlorpheniramine/methscopolamine/PE 2 mg-1.5 mg-10 mg/5 mL extended release: 5 to 10 mL orally every 12 hours daily.
chlorpheniramine/methscopolamine/PE 2 mg-0.625 mg-10 mg/5 mL oral syrup 10 mL orally every 4-6 hours, not to exceed 4 doses per day.
chlorpheniramine/methscopolamine/PE 2 mg-1.25 mg-10 mg/5 mL oral syrup: 5 to 10 mL orally every 3-4 hours.
chlorpheniramine/methscopolamine/PE 2 mg-0.75 mg-8 mg/5 mL: 10 mL orally every 4 to 6 hours daily not to exceed 4 doses in 24 hours.
chlorpheniramine/methscopolamine/PE 2 mg-0.75 mg-10 mg/5 mL: 10 mL orally every 4 to 6 hours daily not to exceed 4 doses in 24 hours.
chlorpheniramine/methscopolamine/PE 4 mg-1.25 mg-10 mg/5 mL: 5 to 10 mL orally every 3 or 4 hours daily.
Usual Adult Dose for Rhinitis
Tablets:
chlorpheniramine/methscopolamine/PE 8 mg-1.25 mg-20 mg, extended release or
chlorpheniramine/methscopolamine/PE 8 mg-2.5 mg-25 mg, extended release or
chlorpheniramine/methscopolamine/PE 8 mg-2.5 mg-40 mg, extended release or
chlorpheniramine/methscopolamine/PE 12 mg-2.5 mg-20 mg extended release or
chlorpheniramine/methscopolamine/PE 12 mg-2 mg-40 mg, extended release or
chlorpheniramine/methscopolamine/PE 8 mg-2.5 mg-20 mg oral tablet, extended release:
1 tablet orally twice a day, not to exceed 2 doses per day.
chlorpheniramine/methscopolamine/PE 4 mg-1.25 mg-10 mg oral tablet or chlorpheniramine/methscopolamine/PE 2 mg-1.25 mg-10 mg oral tablet, chewable: 1 to 2 tablets orally every 12 hours, not to exceed 4 tablets per day.
chlorpheniramine/methscopolamine/PE varying strength oral tablet, extended release:
chlorpheniramine/methscopolamine/PE 2.5 mg-40 mg extended release: 1 tablet orally in the morning and
chlorpheniramine/methscopolamine/PE 8 mg-2.5 mg-10 mg extended release: 1 tablet orally in the evening.
chlorpheniramine/methscopolamine/PE ages 6 years and older oral tablet, extended release
chlorpheniramine/methscopolamine/PE 2 mg-1.5 mg-10 mg extended release: 1 or 2 tablets orally in the morning and
chlorpheniramine/methscopolamine/PE 2 mg--1.5 mg extended release: 1 or 2 tablets orally in the evening.
Liquid:
chlorpheniramine/methscopolamine/PE 2 mg-1.5 mg-10 mg/5 mL extended release: 5 to 10 mL orally every 12 hours daily.
chlorpheniramine/methscopolamine/PE 2 mg-0.625 mg-10 mg/5 mL oral syrup 10 mL orally every 4-6 hours, not to exceed 4 doses per day.
chlorpheniramine/methscopolamine/PE 2 mg-1.25 mg-10 mg/5 mL oral syrup: 5 to 10 mL orally every 3-4 hours.
chlorpheniramine/methscopolamine/PE 2 mg-0.75 mg-8 mg/5 mL: 10 mL orally every 4 to 6 hours daily not to exceed 4 doses in 24 hours.
chlorpheniramine/methscopolamine/PE 2 mg-0.75 mg-10 mg/5 mL: 10 mL orally every 4 to 6 hours daily not to exceed 4 doses in 24 hours.
chlorpheniramine/methscopolamine/PE 4 mg-1.25 mg-10 mg/5 mL: 5 to 10 mL orally every 3 or 4 hours daily.
Usual Pediatric Dose for Nasal Congestion
12 yrs and older:
Tablets:
chlorpheniramine/methscopolamine/PE 8 mg-1.25 mg-20 mg, extended release or
chlorpheniramine/methscopolamine/PE 8 mg-2.5 mg-25 mg, extended release or
chlorpheniramine/methscopolamine/PE 8 mg-2.5 mg-40 mg, extended release or
chlorpheniramine/methscopolamine/PE 12 mg-2.5 mg-20 mg extended release or
chlorpheniramine/methscopolamine/PE 12 mg-2 mg-40 mg, extended release or
chlorpheniramine/methscopolamine/PE 8 mg-2.5 mg-20 mg oral tablet, extended release:
1 tablet orally twice a day, not to exceed 2 doses per day.
chlorpheniramine/methscopolamine/PE 4 mg-1.25 mg-10 mg oral tablet or chlorpheniramine/methscopolamine/PE 2 mg-1.25 mg-10 mg oral tablet, chewable: 1 to 2 tablets orally every 12 hours, not to exceed 4 tablets per day.
chlorpheniramine/methscopolamine/PE varying strength oral tablet, extended release:
chlorpheniramine/methscopolamine/PE 2.5 mg-40 mg extended release: 1 tablet orally in the morning and
chlorpheniramine/methscopolamine/PE 8 mg-2.5 mg-10 mg extended release: 1 tablet orally in the evening.
chlorpheniramine/methscopolamine/PE ages 6 years and older oral tablet, extended release
chlorpheniramine/methscopolamine/PE 2 mg-1.5 mg-10 mg extended release: 1 or 2 tablets orally in the morning and
chlorpheniramine/methscopolamine/PE 2 mg--1.5 mg extended release: 1 or 2 tablets orally in the evening.
Liquid:
chlorpheniramine/methscopolamine/PE 2 mg-1.5 mg-10 mg/5 mL extended release: 5 to 10 mL orally every 12 hours daily.
chlorpheniramine/methscopolamine/PE 2 mg-0.625 mg-10 mg/5 mL oral syrup 10 mL orally every 4-6 hours, not to exceed 4 doses per day.
chlorpheniramine/methscopolamine/PE 2 mg-1.25 mg-10 mg/5 mL oral syrup: 5 to 10 mL orally every 3-4 hours.
chlorpheniramine/methscopolamine/PE 2 mg-0.75 mg-8 mg/5 mL: 10 mL orally every 4 to 6 hours daily not to exceed 4 doses in 24 hours.
chlorpheniramine/methscopolamine/PE 2 mg-0.75 mg-10 mg/5 mL: 10 mL orally every 4 to 6 hours daily not to exceed 4 doses in 24 hours.
chlorpheniramine/methscopolamine/PE 4 mg-1.25 mg-10 mg/5 mL: 5 to 10 mL orally every 3 or 4 hours daily.
6 yrs to 11 yrs:
Liquid:
chlorpheniramine/methscopolamine/PE 4 mg-1.25 mg-10 mg/5 mL: 2.5 to 5 mL orally every 4 hours daily.
chlorpheniramine/methscopolamine/PE 2 mg-0.75 mg-8 mg/5 mL: 5 mL orally every 4 to 6 hours daily not to exceed 4 doses in 24 hours.
chlorpheniramine/methscopolamine/PE 2 mg-0.75 mg-10 mg/5 mL: 5 mL orally every 4 to 6 hours daily not to exceed 4 doses in 24 hours.
chlorpheniramine/methscopolamine/PE 2 mg-1.5 mg-10 mg/5 mL, extended release 2.5 to 5 mL orally every 12 hours daily.
Chew tab:
chlorpheniramine/methscopolamine/PE 2 mg-1.25 mg-15 mg chewable: 1 tablet orally every 4 hours not to exceed 4 tablets per day.
Tablets:
chlorpheniramine/methscopolamine/PE 8 mg-1.25 mg-20 mg, extended release or
chlorpheniramine/methscopolamine/PE 8 mg-2.5 mg-25 mg, extended release or
chlorpheniramine/methscopolamine/PE 8 mg-2.5 mg-40 mg, extended release or
chlorpheniramine/methscopolamine/PE 12 mg-2.5 mg-20 mg, extended release or
chlorpheniramine/methscopolamine/PE 12 mg-2 mg-40 mg, extended release:
1/2 tablet orally twice daily, not to exceed 2 doses per day.
chlorpheniramine/methscopolamine/PE 2 mg-1.25 mg-10 mg oral tablet, chewable: 1/2 to 1 tablet orally every 12 hours, not to exceed 2 tablets per day.
chlorpheniramine/methscopolamine/PE ages 6 years and older oral tablet, extended release
chlorpheniramine/methscopolamine/PE 2 mg-1.5 mg-10 mg extended release: 1/2 to 1 tablet orally in the morning and
chlorpheniramine/methscopolamine/PE 2 mg--1.5 mg extended release: 1/2 to 1 tablet orally in the evening.
Usual Pediatric Dose for Rhinitis
12 yrs and older:
Tablets:
chlorpheniramine/methscopolamine/PE 8 mg-1.25 mg-20 mg, extended release or
chlorpheniramine/methscopolamine/PE 8 mg-2.5 mg-25 mg, extended release or
chlorpheniramine/methscopolamine/PE 8 mg-2.5 mg-40 mg, extended release or
chlorpheniramine/methscopolamine/PE 12 mg-2.5 mg-20 mg extended release or
chlorpheniramine/methscopolamine/PE 12 mg-2 mg-40 mg, extended release or
chlorpheniramine/methscopolamine/PE 8 mg-2.5 mg-20 mg oral tablet, extended release:
1 tablet orally twice a day, not to exceed 2 doses per day.
chlorpheniramine/methscopolamine/PE 4 mg-1.25 mg-10 mg oral tablet or chlorpheniramine/methscopolamine/PE 2 mg-1.25 mg-10 mg oral tablet, chewable: 1 to 2 tablets orally every 12 hours, not to exceed 4 tablets per day.
chlorpheniramine/methscopolamine/PE varying strength oral tablet, extended release:
chlorpheniramine/methscopolamine/PE 2.5 mg-40 mg extended release: 1 tablet orally in the morning and
chlorpheniramine/methscopolamine/PE 8 mg-2.5 mg-10 mg extended release: 1 tablet orally in the evening.
chlorpheniramine/methscopolamine/PE ages 6 years and older oral tablet, extended release
chlorpheniramine/methscopolamine/PE 2 mg-1.5 mg-10 mg extended release: 1 or 2 tablets orally in the morning and
chlorpheniramine/methscopolamine/PE 2 mg--1.5 mg extended release: 1 or 2 tablets orally in the evening.
Liquid:
chlorpheniramine/methscopolamine/PE 2 mg-1.5 mg-10 mg/5 mL extended release: 5 to 10 mL orally every 12 hours daily.
chlorpheniramine/methscopolamine/PE 2 mg-0.625 mg-10 mg/5 mL oral syrup 10 mL orally every 4-6 hours, not to exceed 4 doses per day.
chlorpheniramine/methscopolamine/PE 2 mg-1.25 mg-10 mg/5 mL oral syrup: 5 to 10 mL orally every 3-4 hours.
chlorpheniramine/methscopolamine/PE 2 mg-0.75 mg-8 mg/5 mL: 10 mL orally every 4 to 6 hours daily not to exceed 4 doses in 24 hours.
chlorpheniramine/methscopolamine/PE 2 mg-0.75 mg-10 mg/5 mL: 10 mL orally every 4 to 6 hours daily not to exceed 4 doses in 24 hours.
chlorpheniramine/methscopolamine/PE 4 mg-1.25 mg-10 mg/5 mL: 5 to 10 mL orally every 3 or 4 hours daily.
6 yrs to 11 yrs:
Liquid:
chlorpheniramine/methscopolamine/PE 4 mg-1.25 mg-10 mg/5 mL: 2.5 to 5 mL orally every 4 hours daily.
chlorpheniramine/methscopolamine/PE 2 mg-0.75 mg-8 mg/5 mL: 5 mL orally every 4 to 6 hours daily not to exceed 4 doses in 24 hours.
chlorpheniramine/methscopolamine/PE 2 mg-0.75 mg-10 mg/5 mL: 5 mL orally every 4 to 6 hours daily not to exceed 4 doses in 24 hours.
chlorpheniramine/methscopolamine/PE 2 mg-1.5 mg-10 mg/5 mL, extended release 2.5 to 5 mL orally every 12 hours daily.
Chew tab:
chlorpheniramine/methscopolamine/PE 2 mg-1.25 mg-15 mg chewable: 1 tablet orally every 4 hours not to exceed 4 tablets per day.
Tablets:
chlorpheniramine/methscopolamine/PE 8 mg-1.25 mg-20 mg, extended release or
chlorpheniramine/methscopolamine/PE 8 mg-2.5 mg-25 mg, extended release or
chlorpheniramine/methscopolamine/PE 8 mg-2.5 mg-40 mg, extended release or
chlorpheniramine/methscopolamine/PE 12 mg-2.5 mg-20 mg, extended release or
chlorpheniramine/methscopolamine/PE 12 mg-2 mg-40 mg, extended release:
1/2 tablet orally twice daily, not to exceed 2 doses per day.
chlorpheniramine/methscopolamine/PE 2 mg-1.25 mg-10 mg oral tablet, chewable: 1/2 to 1 tablet orally every 12 hours, not to exceed 2 tablets per day.
chlorpheniramine/methscopolamine/PE ages 6 years and older oral tablet, extended release
chlorpheniramine/methscopolamine/PE 2 mg-1.5 mg-10 mg extended release: 1/2 to 1 tablet orally in the morning and
chlorpheniramine/methscopolamine/PE 2 mg--1.5 mg extended release: 1/2 to 1 tablet orally in the evening.
Renal Dose Adjustments
Data not available
Liver Dose Adjustments
Data not available
Dialysis
Data not available
More about chlorpheniramine / methscopolamine / phenylephrine
- Check interactions
- Compare alternatives
- Reviews (6)
- Drug images
- Side effects
- During pregnancy
- Drug class: upper respiratory combinations
- En español
Patient resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
